ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE
MWN-AI** Summary
The Italian Trade Agency (ITA) is set to host the "Italy on the Move 2025" event during the prestigious J.P. Morgan Healthcare Conference in San Francisco, showcasing Italy's strength in the biotechnology, healthcare, medical devices, and pharmaceuticals sectors. The event will take place on January 15, 2025, at INNOVIT, the Italian Innovation and Culture Hub, and aims to attract investments and facilitate partnerships in Italy's thriving life sciences market valued at €270 billion, which significantly contributes to the country's GDP.
The event will feature influential figures such as H.E. Mariangela Zappia, the Ambassador of Italy to the U.S., and the Consul General of Italy in San Francisco, Sergio Strozzi. They will emphasize Italy's robust life sciences ecosystem, which is already home to nearly 50 multinational companies involved in production and research and development. Mauro Battocchi, Director General for the Promotion of the Italy System, will provide insights into the sector's economic impact and growth potential.
"Italy on the Move" has become a platform since its inception in 2016 for connecting U.S. healthcare companies and investors with Italian firms. The 2025 edition will include discussions on transatlantic partnerships, featuring a panel of esteemed leaders in the life sciences space. Additionally, five innovative Italian startups will present their proposals, highlighting the dynamic opportunities within the Italian market.
This event represents a pivotal moment for American investors and firms to explore Italy's significant position as the leading economy in the European Union's pharmaceutical contract development and manufacturing sector, as well as its strong productivity in life sciences patents globally.
MWN-AI** Analysis
The upcoming “Italy on the Move 2025” event, hosted by the Italian Trade Agency during the J.P. Morgan Healthcare Conference, presents a ripe opportunity for investors focusing on the life sciences sector. With the Italian life sciences industry valued at €270 billion, it represents an essential segment of Italy’s economy, accounting for approximately 11% of the country's GDP.
This event will feature prominent Italian healthcare executives and innovative start-ups, making it a compelling venue for U.S. companies and investors seeking international partnerships. The presence of top-tier executives from reputable firms like Menarini Group and Bracco Imaging underscores the credibility of the Italian life sciences market. Notably, Italy ranks first in the European Union for pharma Contract Development and Manufacturing Organization (CDMO) value and fourth globally for patent productivity in life sciences, indicating a robust R&D environment.
Participants should consider the potential for collaboration with innovative SMEs showcased during the dedicated pitch sessions. These startups are crucial for accessing cutting-edge technologies and groundbreaking treatment solutions. As the healthcare sector pivots towards innovation, investments in these companies could yield significant returns.
The emphasis on transatlantic partnerships at “Italy on the Move” signals the increasing importance of international collaboration in the life sciences. U.S. investors are encouraged to engage with Italian counterparts for insights into emerging trends, regulatory environments, and investment opportunities within this dynamic market.
Overall, attending this event could not only enrich one’s understanding of the Italian life sciences landscape but also provide critical networking opportunities with key industry stakeholders, positioning investors favorably in the global health economy.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
Event showcases Italy as leading competitive hub for investments in biotech, healthcare, medical devices, and pharmaceuticals, and includes experts discussing private and public/institutional financial opportunities in the €270 Billion Italian life sciences sector 1
SAN FRANCISCO , Jan. 8, 2025 /PRNewswire/ -- To promote investment opportunities in Italy in 2025, the Italian Trade Agency (ITA) and the Ministry of Foreign Affairs and International Cooperation will be hosting the eighth edition of " Italy on the Move," a side event of the 43 rd annual J.P. Morgan Healthcare Conference 2025. The event will take place at INNOVIT (710 Sansome Street), San Francisco's Italian Innovation and Culture Hub, starting at 5:00 PM on Wednesday, January 15, 2025 .
Opening remarks at the event will be from the Ambassador of Italy to the U.S. H.E. Mariangela Zappia and Consul General of Italy in San Francisco Sergio Strozzi .
The Italian life sciences ecosystem overview will be provided by Keynote Speaker Mauro Battocchi , the Director General for the Promotion of the Italy System at the Italian Ministry of Foreign Affairs and International Cooperation, who noted, " With a turnover of 270bn euros (equivalent to 11% of the country's GDP), Lifesciences are a powerhouse of the Italian economy. Thriving pharma, biotech and medical devices industries have attracted nearly 50 life science multinationals to set base in Italy for their productions and R&D activities. But there's ample room for growth! " Italy on the Move," organized by the Italian Foreign Ministry and the Italian Trade Agency (and hosted, in conjunction with the JP Morgan Healthcare Conference in San Francisco , at the Italian Innovation Center in Silicon Valley – INNOVIT) is the place to get to know more about the potentials the Italian life science ecosystems have to offer to international scientists, researchers, companies and investors. "
Ambassador Zappia said, " Italy's life sciences sector is large and fast growing, encompassing medical devices, pharmaceuticals, and healthcare services. Pharmaceuticals and medical devices represent the third most significant Italian export in the world, well before more iconic "Made in Italy " goods, such as apparels or wines. We cannot think of a better partner than the United States ."
Consul General Strozzi emphasized, " Italy on the Move is the event in San Francisco where US Healthcare Companies and Investors can meet Italian Companies to partner with or to invest in. It represents a unique occasion to know more about Italy ranking as 1st among the EU economies by pharma CDMO manufacturing value and 4th worldwide by patents productivity in Life Sciences [2] . I invite all American Life Sciences leaders and investors to join us at INNOVIT. "
"Since 2016, Italy on the Move has been the annual appointment with the Italian life sciences industry in the United States ," said Erica Di Giovancarlo, ITA's Trade Commissioner in New York and Executive Director of the U.S. Network. "For this 8th edition, we are proud to present some of the best players in the Italian industry alongside relevant American counterparts, with the opportunity to get to know innovative SMEs and startups during a dedicated pitch event."
The event will also include a panel discussion, "Navigating Transatlantic Partnerships in Life Sciences," moderated by Audrey Greenberg , Founder of the Center for Breakthrough Medicines and CEO and Founder of AG Capital Advisors.
Panelists include leading life sciences executives:
- Frederick Beddingfield - CEO, Rubedo Life Sciences
- Fulvio Renoldi Bracco - CEO, Bracco Imaging
- Elcin Barker Ergun - CEO and Member of the Board, Menarini Group
- Karthic Jayaraman - Partner and Co-Head of Global Healthcare, TPG Capital
- Pierluigi Paracchi - CEO, Co-Founder and Chairman, Genenta Science (Nasdaq: GNTA)
- Maria Cristina Porta - General Director, ENEA Tech and Biomedical
- Riccardo Zagaria - CEO, DOC Pharma
In addition, five key Italian startups will provide pitch presentations, specifically Aavantgarde , Butterfly Decisions , Cellply , Medlea , and Sibylla Biotech .
About the Italian Trade Agency
The Italian Trade Agency is the government agency which promotes the globalization of Italian firms under the aegis of the Ministry of Foreign Affairs. ITA helps to develop, facilitate and promote Italian economic and trade relations with foreign countries, focusing on the needs of SMEs, their associations and partnerships. ITA sustains Italian firms in their internationalization process, promoting the marketing of Italian goods and services as well as the image of "Made in Italy " products around the world, while facilitating outward Italian investments and encouraging FDI attraction into Italy . ITA's headquarters are based in Rome , and it works through a large network of offices around the world which are acknowledged as "Trade Promotion Offices" of the Embassies or Consulates of Italy . https://www.ice.it/en/
LinkedIn: https://www.linkedin.com/company/italosangeles/
Twitter: https://twitter.com/ITALosAngeles
Facebook: https://www.facebook.com/italosangeles
About INNOVIT
The Italian Innovation and Culture Hub INNOVIT is a strategic initiative of the Italian Government for the promotion of the Country System's innovation in the United States . Its mission is to foster the Italian innovative companies, startups and tech ecosystems by connecting them with the Silicon Valley and US ones.
Web: innovitsf.com
LinkedIn: innovitsf
Media Contact for Event Queries and Attendance
Peter Collins
p.collins@togorun.com
908-499-1200
__________________________
1 Assolombarda. (2024, July). La rilevanza della filiera Life Science in Lombardia https://www.assolombarda.it/centro-studi/la-rilevanza-della-filiera-life-science-in-lombardia-edizione-2024 Accessed 1 January 2024 .
2 https://www.investinitaly.gov.it/en/sectors/life-sciences
SOURCE Italian Trade Agency
FAQ**
How does the participation of Genenta Science S.p.A. (GNTA) at the "Italy on the Move 2025" event reflect the potential for innovative partnerships within the Italian life sciences sector?
What specific investments is Genenta Science S.p.A. (GNTA) seeking during the "Italy on the Move 2025" side event to enhance its biotech capabilities and R&D initiatives?
In what ways can U.S. investors leverage insights from Genenta Science S.p.A. (GNTA) and other Italian companies featured at the event to foster transatlantic collaborations in life sciences?
How does Genenta Science S.p.A. (GNTA)'s presence at the J.P. Morgan Healthcare Conference signify the growth opportunities in Italy's €270 Billion life sciences sector for international stakeholders?
**MWN-AI FAQ is based on asking OpenAI questions about Genenta Science S.p.A. (NASDAQ: GNTA).
NASDAQ: GNTA
GNTA Trading
13.11% G/L:
$2.07 Last:
5,067,771 Volume:
$1.59 Open:
